Glucagon-like peptide-1 (GLP-1) agonists, initially indicated for treatment of T2D, are the newest FDA-approved AOMs
Side effects and safety warnings Patients taking semaglutide report experiencing gastrointestinal-related side effects, including vomiting, nausea, diarrhea, constipation, headache, and fatigue
Red blood cells carry oxygen to the brain and other organs, causing a lack of energy and depression without them
Shelf life after reconstitution Reconstituted retatrutide in bacteriostatic water maintains potency for approximately 28 to 30 days when stored properly at 2 to 8 degrees Celsius
Side Effects can be swelling, redness, tingling or numbness, drainage at the injection site, prolonged bleeding, and possibly some pain at the injection site